Showing results (201-210 of 277) with videos related to
Sort By:
Pageof 28
The Journal of Dermatological Treatment|January 16, 2016
A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasisRobert Bissonnette, Monica Luchi, Rosanne Fidelus-Gort, et al.Human Genetics|December 17, 2002
Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibilityRebecca A Speckman, Jil A Wright Daw, Cynthia Helms, et al.Journal of the American Academy of Dermatology|November 14, 2006
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasisAlan Menter, Steven R Feldman, Gerald D Weinstein, et al.Journal of the American Academy of Dermatology|October 7, 2008
Psoriasis: improving adherence to topical therapySteven R Feldman, Elizabeth J Horn, Rajesh Balkrishnan, et al.Journal of Drugs in Dermatology : JDD|April 3, 2008
Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomesLeon Kircik, Jerry Bagel, Neil Korman, et al.The Journal of Dermatological Treatment|December 7, 2007
Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasisDennis A Revicki, Mary Kaye Willian, Alan Menter, et al.Dermatology (Basel, Switzerland)|October 13, 2006
A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque psoriasisCraig L Leonardi, Darryl Toth, Jennifer C Cather, et al.Dermatology and Therapy|August 18, 2017
Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT RegistryAlan Menter, Diamant Thaçi, Jashin J Wu, et al.Journal of the American Academy of Dermatology|November 4, 2004
Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized studyCarin Gribetz, Mark Ling, Mark Lebwohl, et al.Journal of the American Academy of Dermatology|March 12, 2005
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trialCraig L Leonardi, Kim A Papp, Kenneth B Gordon, et al.Pageof 28